Prevention of vertical transmission of hepatitis B virus by yeast recombinant hepatitis B vaccine. 1989

R Murata, and G Isshiki, and H Yoshioka, and Y Chiba, and H Tada, and M Koike, and M Kimura

In order to prevent vertical transmission of hepatitis B virus (HBV), yeast recombinant HB vaccine at a dose of either 5 mcg or 10 mcg was administered to 185 infants born to mothers who were positive for HBs antigen (HBsAg). All of them developed antibody to HBsAg (anti-HBs) after three vaccinations. Generally, the cut-off index (COI) of anti-HBs by radioimmunoassay (RIA) was higher in the 10 mcg dosage group than in the 5 mcg dosage group. The geometric mean titer (GMT) of anti-HBs, as measured by quantitative RIA, in the former group was 2.4 times that in the latter one month after the third vaccination. The incidence of clinical reactions was only 4% in a total of 561 injections, and none of the reactions were severe. It is concluded that recombinant HB vaccine is safe and has excellent immunogenicity for infants requiring prevention of HBV vertical transmission. It is also suggested that 10 mcg doses of the recombinant HB vaccine can provide more solid protection to high-risk infants without serious adverse reactions.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008431 Maternal-Fetal Exchange Exchange of substances between the maternal blood and the fetal blood at the PLACENTA via PLACENTAL CIRCULATION. The placental barrier excludes microbial or viral transmission. Transplacental Exposure,Exchange, Maternal-Fetal,Exposure, Transplacental,Maternal Fetal Exchange
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011251 Pregnancy Complications, Infectious The co-occurrence of pregnancy and an INFECTION. The infection may precede or follow FERTILIZATION. Complications, Infectious Pregnancy,Infectious Pregnancy Complications,Maternal Sepsis,Pregnancy, Infectious Complications,Sepsis during Pregnancy,Sepsis in Pregnancy,Infectious Pregnancy Complication,Pregnancy Complication, Infectious,Sepsis in Pregnancies,Sepsis, Maternal
D002353 Carrier State The condition of harboring an infective organism without manifesting symptoms of infection. The organism must be readily transmissible to another susceptible host. Asymptomatic Carrier State,Asymptomatic Infection Carrier,Inapparent Infection Carrier,Presymptomatic Carrier State,Presymptomatic Infection Carrier,Super-spreader Carrier,Superspreader Carrier,Asymptomatic Carrier States,Asymptomatic Infection Carriers,Carrier State, Asymptomatic,Carrier State, Presymptomatic,Carrier States,Carrier, Super-spreader,Carrier, Superspreader,Carriers, Super-spreader,Carriers, Superspreader,Inapparent Infection Carriers,Infection Carrier, Asymptomatic,Infection Carrier, Inapparent,Infection Carrier, Presymptomatic,Presymptomatic Carrier States,Presymptomatic Infection Carriers,Super spreader Carrier,Super-spreader Carriers,Superspreader Carriers
D005260 Female Females
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006510 Hepatitis B Antibodies Antibodies to the HEPATITIS B ANTIGENS, including antibodies to the surface (Australia) and core of the Dane particle and those to the "e" antigens. Anti-Australia Antigens,Anti-HBAg,Anti-Hepatitis B Antigens,Anti HBAg,Hepatitis B Virus Antibodies,Anti Australia Antigens,Anti Hepatitis B Antigens,Antibodies, Hepatitis B,Antigens, Anti-Australia,Antigens, Anti-Hepatitis B,B Antibodies, Hepatitis,B Antigens, Anti-Hepatitis,HBAg, Anti
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012449 Safety Freedom from exposure to danger and protection from the occurrence or risk of injury or loss. It suggests optimal precautions in the workplace, on the street, in the home, etc., and includes personal safety as well as the safety of property. Safeties

Related Publications

R Murata, and G Isshiki, and H Yoshioka, and Y Chiba, and H Tada, and M Koike, and M Kimura
May 1987, JAMA,
R Murata, and G Isshiki, and H Yoshioka, and Y Chiba, and H Tada, and M Koike, and M Kimura
November 1991, Zhonghua fu chan ke za zhi,
R Murata, and G Isshiki, and H Yoshioka, and Y Chiba, and H Tada, and M Koike, and M Kimura
July 1986, The Journal of infection,
R Murata, and G Isshiki, and H Yoshioka, and Y Chiba, and H Tada, and M Koike, and M Kimura
July 2021, World journal of gastroenterology,
R Murata, and G Isshiki, and H Yoshioka, and Y Chiba, and H Tada, and M Koike, and M Kimura
January 1986, Developments in biological standardization,
R Murata, and G Isshiki, and H Yoshioka, and Y Chiba, and H Tada, and M Koike, and M Kimura
January 1987, Infection,
R Murata, and G Isshiki, and H Yoshioka, and Y Chiba, and H Tada, and M Koike, and M Kimura
January 1986, The Netherlands journal of medicine,
R Murata, and G Isshiki, and H Yoshioka, and Y Chiba, and H Tada, and M Koike, and M Kimura
May 1984, Zhonghua yi xue za zhi,
R Murata, and G Isshiki, and H Yoshioka, and Y Chiba, and H Tada, and M Koike, and M Kimura
November 2014, Annals of internal medicine,
R Murata, and G Isshiki, and H Yoshioka, and Y Chiba, and H Tada, and M Koike, and M Kimura
May 1988, Indian pediatrics,
Copied contents to your clipboard!